King & Spalding advised TVM Capital Healthcare on its $35 million investment into Boston Oncology Arabia, a manufacturer and distributor of biogeneric drugs operating in Saudi Arabia. The investment into Boston Oncology Arabia helps to increase
King & Spalding advised TVM Capital Healthcare on its $35 million investment into Boston Oncology Arabia, a manufacturer and distributor of biogeneric drugs operating in Saudi Arabia. The investment into Boston Oncology Arabia helps to increase